Cargando…

Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021

Detalles Bibliográficos
Autor principal: Anesi, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805400/
https://www.ncbi.nlm.nih.gov/pubmed/34967123
http://dx.doi.org/10.1111/ajt.16910
_version_ 1784862329488277504
author Anesi, Judith
author_facet Anesi, Judith
author_sort Anesi, Judith
collection PubMed
description
format Online
Article
Text
id pubmed-9805400
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98054002023-01-04 Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021 Anesi, Judith Am J Transplant Cdc Report American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022-01 2022-12-30 /pmc/articles/PMC9805400/ /pubmed/34967123 http://dx.doi.org/10.1111/ajt.16910 Text en Copyright © 2002 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Cdc Report
Anesi, Judith
Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title_full Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title_fullStr Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title_full_unstemmed Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title_short Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021
title_sort commentary: effectiveness of two-dose vaccination with mrna covid-19 vaccines against covid-19-associated hospitalizations among immunocompromised adults—nine states, january–september 2021
topic Cdc Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805400/
https://www.ncbi.nlm.nih.gov/pubmed/34967123
http://dx.doi.org/10.1111/ajt.16910
work_keys_str_mv AT anesijudith commentaryeffectivenessoftwodosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021